WHO launches Global Plan for Insecticide Resistance Management in malaria vectors (GPIRM)
15 May, 2012 The WHO Global Malaria Programme and the Roll Back Malaria Partnership have launched a global plan to tackle the emerging threat of mosquito resistance to insecticides. WHO and RBM urge affected countries and stakeholders to take action to preserve the effectiveness of current vector control tools, and to ensure that a new generation of public health insecticides is made available soon.
Issue brief on the status of drug resistance along the Thailand-Myanmar border
09 May 2012 This issue brief looks at the status of emerging antimalarial drug resistance along the Thailand-Myanmar border and highlights the importance of scaling up prevention and containment efforts. Artemisinin-based combination therapies remain effective in the Greater Mekong sub-region but there is an urgent need to contain drug-resistant parasites where they have emerged.
24 April, 2012 On World Malaria Day 2012, WHO hails global progress in combating malaria but highlights the need to further reinforce the fight. The Global Malaria Programme’s new initiative, T3: Test. Treat. Track, urges malaria-endemic countries and donors to move towards universal access to diagnostic testing and antimalarial treatment, and to build stronger malaria surveillance systems.
Just published: Disease Surveillance for Malaria Control & Elimination
24 April 2012 Two new manuals have been published to help countries build effective surveillance systems for malaria. Strengthened surveillance for malaria cases and deaths will help ministries of health and international aid programmes to determine which areas or population groups are most affected. It will also help to identify resurgences and map new trends - thus maximizing the efficiency of prevention and control programmes.
New policy recommendation: Seasonal Malaria Chemoprevention in highly seasonal transmission areas of the Sahel sub-region
28 March 2012 WHO has released a new recommendation on Seasonal Malaria Chemoprevention (SMC) for P. falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. This treatment was previously referred to as Intermittent Preventive Treatment in children (IPTc).
Report: Inaugural meeting of the Malaria Policy Advisory Committee
20 March 2012 The Malaria Policy Advisory Committee (MPAC) met for the first time on 31 January - 2 February, 2012 in Geneva. This report provides a summary of the discussions, conclusions and recommendations from that meeting. This and all future MPAC reports will be published both on the Global Malaria Programme web site and in the Malaria Journal.
About the WHO Global Malaria Programme The Global Malaria Programme (GMP) is responsible for malaria surveillance, monitoring and evaluation, policy and strategy formulation, technical assistance, and coordination of WHO's global efforts to fight malaria.
The analysis of supply plans for artemether-lumefantrine of the four WHO-prequalified manufacturers - notably Ajanta, Cipla, Ipca and Novartis - shows that the termination of the Memorandum of Understanding between WHO and Novartis for the supply of Coartem® at cost will not affect the global supply capacity of artemether-lumefantrine in the near future.
Marketing of oral artemisinin-based monotherapy medicines The position of manufacturing companies and national drug regulatory authorities in relation to WHO’s appeal to withdraw the marketing authorization of oral artemisinin-based monotherapy medicines is monitored on a regular basis.
WHO has normative, standard setting and policy-making roles in malaria vaccine development. WHO also facilitates information-sharing and coordination at the global level.
